FREE PAPER HCV TREATMENT O‐24: The German multicenter cohort on direct antiviral agents in HCV‐ and HIV/HCV‐infected patients (GECODAA)

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|14-15

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 14-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P139: Development of treatment model for HIV/HCV co‐infected OST patients as the basis for scaling up access to HCV treatment for key populations in Ukraine

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 89-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylaxis of HCV reinfection and direct‐acting antiviral agents during liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 10, 2015-10 ,pp. : 1327-1329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylaxis of HCV reinfection and direct‐acting antiviral agents during liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 1527-6465, Iss. 10, 2015-10 ,pp. : 1327-1329

John Wiley & Sons Inc

Access to resources Recommend Favorite

P134: Eligibility for actual antiviral treatment of chronically hcv infected patients addressed to a tertiary referral hepatology center

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 88-88

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct‐acting antiviral treatment for HCV

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 1, 2018-01 ,pp. : 76-83

John Wiley & Sons Inc

Access to resources Recommend Favorite